… A protease inhibitor called nirmatrelvir coupled with ritonavir (… first oral antiviral against COVID-19, ie, nirmatrelvir/ritonavir (… regarding the use of nirmatrelvir/ritonavir in clinical practice …
F Tian, Z Chen, Q Feng - Journal of Medical Virology, 2023 - Wiley Online Library
… for the treatment of COVID-19 patients. We aimed to evaluate the efficacy and safety … nirmatrelvir–ritonavir compared with other antiviraldrugs and the impact of different antiviraldrugs …
… inhibitor, ritonavir, to create Paxlovid (Nirmatrelvir/Ritonavir). … is inhibited by ritonavir to lengthen the half-life of nirmatrelvir, … the current literature on nirmatrelvir and ritonavir efficacy in …
C Marzolini, DR Kuritzkes, F Marra… - Clinical …, 2022 - Wiley Online Library
… drugs that are an absolute contraindication for use with nirmatrelvir/ritonavir but also know which drugs … to prevent unnecessary denial of nirmatrelvir/ritonavirtreatment or inappropriate …
… the impact of nirmatrelvir/ritonavir and determine strategy policies for the treatment of vulnerable … Our study analyzes the effect of nirmatrelvir/ritonavirtreatment on 28-day recovery, …
Y Gao, Z Luo, S Ren, Z Duan, Y Han, H Liu… - The Journal of …, 2023 - ncbi.nlm.nih.gov
… Unlike the wealth of available data for nirmatrelvir-ritonavir, 5 there is limited information … trial for antiviralagents, there is a need to understand antivirals effect of available agents in …
… These recommendations intend to be a help for clinicians willing to prescribe nirmatrelvir/ritonavir and to prevent drug-drug interactions leading to adverse drug reactions or loss of …
… Nirmatrelvir plus ritonavir is authorized for emergency use in the USA. This article … nirmatrelvir plus ritonavir leading to its first authorizations and approval for the treatment of COVID-19. …
CY Hu, WS Cui, Y Lei, YW Tang, YY Zhang… - Infection and Drug …, 2023 - Taylor & Francis
… than nirmatrelvir/ritonavir is. Citation12 Choosing between azvudine and nirmatrelvir/ritonavir for COVID-19 treatment … understand the treatment choice between nirmatrelvir/ritonavir and …